Twist Bioscience Corp (TWST) income statement
TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30208% above fair value
$103.32−8.30 (-7.44%)
Close on Nov 20, 2026Market cap $6.48BP/E –Yield –
Twist Bioscience Corp financial ratios
See a number that looks wrong?